[Video Profile] CoreSpine Technologies
CoreSpine Technologies is a Minneapolis, MN-based orthopedics company developing a device to prepare the spinal disc space prior to surgery. The company’s platform removes material […]
news2
[Device Profile] Sunshine Heart’s C-Pulse
Good news for the 1.4 million U.S. patients now living with moderate heart failure: Sunshine Heart is developing a new mechanical heart assist device, C-Pulse. […]
Biolase Cuts Jobs Citing a Weak Capital Equipment Marketplace
Dental laser maker Biolase Technology has slashed 20 percent of its domestic workforce. The company will save $2 million a quarter as a result. Additional […]
DexCom: CE Mark Approval for Continuous Glucose Monitor
DexCom’s short term continuous glucose monitor, The Seven, has received CE Mark approval enabling commercialization in the EU and the countries in Asia and Latin […]
Terminated: Minrad International Ends Agreement with RxElite
Minrad International has terminated its distribution agreement with RxElite. The action was taken after the RxElite failed to pay $5.6 million in accounts owed to […]
[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based […]
Trod Medical: FDA 510(k) Clearance for Encage
Trod Medical has received FDA 510(k) clearance for Encage, a minimally invasive technology for soft tissue ablation. The surgical system allows for precise percutaneous ablation […]
SyntheMed: FDA Clearance for SinusShield
SyntheMed, of Iselin, NJ, has received FDA 510(k) clearance for SinusShield, a bioresorbable membrane to prevent post-operative adhesions from forming after nasal and sinus surgeries. […]
Candela Buys Some Time
Shares of Candela Corporation, a maker of aesthetic lasers, jumped 31% yesterday after the U.S. District Court agreed to postpone the patent litigation suit brought […]
[Video Profile] Interview with Eric Le Royer, CEO of EndoSense SA
Endosense is developing a catheter ablation treatment for cardiac rhythm disorders, including atrial fibrillation (AF). AF is the most common cardiac rhythm disorder today, affecting […]